Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 17,464.11 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Shares of NATCO Pharma tumbled another 10% in intra-day trade on Friday, February 14, extending its slide to the sixth straight session. The stock had tumbled 20% on Thursday as well following the ...

Natco Pharma Shares Plummet 18.5%! In a stunning turn of events, Natco Pharma shares took a nosedive on February 13, 2025, leaving investors and market watchers in shock. The pharmaceutical giant, ...

Natco Pharma Ltd shares tanked during the early trading session on Thursday, February 13, 2025, after it announced weak third quarter financial results. Natco Pharma Ltd. shares tanked during the ...

Natco Pharma share price tanked 19 per cent to Rs 986 on the BSE in Thursday’s intra-day trade amid heavy volumes after the company reported a weak set of numbers in its December 2024 quarter (Q3FY25) ...

NATCO Pharma Ltd on Wednesday reported a 37.75 per cent decline in consolidated net profit to Rs 132.4 crore in the December quarter, hit by a drop in formulations exports. NATCO Pharma Ltd on ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active ...

Natco Pharma share price slumped nearly 19% on Thursday, in an otherwise positive broader market, after the Hyderabad-based drug maker as investors weighed weak December quarter earnings. The smallcap ...

NATCO Pharma Ltd reported a 37.75 per cent decline in consolidated net profit to ₹132.4 crore for Q3 FY2025, down from ₹212.7 crore in the same quarter last year. The company’s shares ...

Natco Pharma results were impacted by a sharp decline in the export formulation business, the biggest revenue contributor for the firm. Natco Pharma plans to launch its CTPR products very shortly, ...

Natco Pharma Q3 Results 2025:Natco Pharma declared their Q3 results on 12 Feb, 2025, revealing a significant decline in both revenue and profit. The company reported a profit of ₹133 crore ...

NATCO Pharma shares tumbled 20% on Thursday after the company reported a 37.75% decline in consolidated net profit in the December quarter, driven by a drop in formulation exports. New Delhi, Feb 13 ...